Zacks Investment Research
15 Dec 2025, 12:01 UTC · 46w ago
Impact · against what's priced in
The potential reclassification of marijuana to Schedule III is a major catalyst for the sector, significantly improving tax profiles and banking access. This news has already triggered a massive immediate rally in cannabis ETFs and stocks, shifting the baseline for future valuations.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish
President Trump reportedly plans to reclassify marijuana from Schedule I to Schedule III early next year.
More positive than 99% of claims this week
Federal reclassification would allow cannabis companies to operate under more favorable tax regulations and facilitate easier access to banking services.
Continue reading
5 related stories
Reports of President Trump's plan to reclassify marijuana to Schedule III early next year provide a fundamental shift in legal risk and tax burdens.
Read from the article alone
No priced-in read yet
The ETF's record-breaking 54% gain reflects the market's reaction to potential federal reclassification, which would ease investment restrictions.
Read from the article alone
No priced-in read yet
Optimism regarding federal reclassification is driving a massive sector surge, as moving to Schedule III would unlock pharmaceutical acceptance.
Read from the article alone
Scored by the NIS engine · methodology.
More positive than 92% of claims this week
Cannabis ETFs and stocks saw massive single-day gains on December 12, 2025, with some ETFs like WEED and CNBS rising over 50%.
More positive than 60% of claims this week
Which stocks this story touches
More positive than 98% of ticker scores this week
The ETF rose 42.8% following positive reports regarding federal marijuana policy changes.
More positive than 98% of ticker scores this week
The ETF rallied more than 54% on its best day on record due to positive regulatory news.
More positive than 98% of ticker scores this week
The ETF rose 54.3% due to optimism surrounding potential federal reclassification of cannabis.
More positive than 98% of ticker scores this week
The company is part of the cannabis sector seeing significant surges due to potential federal reclassification to Schedule III.
More positive than 98% of ticker scores this week
The ETF rose 55.7% following reports of eased federal marijuana regulations.
More positive than 98% of ticker scores this week
The ETF rose 34.5% as part of a broad cannabis sector surge.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
WSJ
1h ago
−38.4%
Price is moving against the score
$23.58 vs $38.29 close before publication (Dec 12) · not market-adjusted
MJ chart →−26.9%
Price is moving against the score
$25.47 vs $34.82 close before publication (Dec 12) · not market-adjusted
CNBS chart →−22.6%
Price is moving against the score
$4.49 vs $5.80 close before publication (Dec 12) · not market-adjusted
MSOS chart →
